Abbvie Inc [NYSE: ABBV] closed the trading session at $162.73.
The stocks have a year to date performance of 5.01 percent and weekly performance of 0.75 percent. The stock has been moved at 13.59 percent over the last six months. The stock has performed -4.28 percent around the most recent 30 days and changed -4.98 percent over the most recent 3-months.
If compared to the average trading volume of 5.74M shares, ABBV reached to a volume of 5733957 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Abbvie Inc [ABBV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABBV shares is $184.04 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Abbvie Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on January 29, 2024. The new note on the price target was released on December 18, 2023, representing the official price target for Abbvie Inc stock.
The Average True Range (ATR) for Abbvie Inc is set at 3.61, with the Price to Sales ratio for ABBV stock in the period of the last 12 months amounting to 5.30. The Price to Book ratio for the last quarter was 35.89, with the Price to Cash per share for the same quarter was set at 10.20. Price to Free Cash Flow for ABBV in the course of the last twelve months was 13.19 with Quick ratio for the last quarter at 0.83.
ABBV stock trade performance evaluation
Abbvie Inc [ABBV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.75. With this latest performance, ABBV shares dropped by -4.28% in over the last four-week period, additionally plugging by 13.59% over the last 6 months – not to mention a rise of 10.43% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ABBV stock in for the last two-week period is set at 41.35, with the RSI for the last a single of trading hit 42.66, and the three-weeks RSI is set at 41.89 for Abbvie Inc [ABBV]. The present Moving Average for the last 50 days of trading for this stock 172.76, while it was recorded at 162.34 for the last single week of trading, and 157.58 for the last 200 days.
Abbvie Inc [ABBV]: An insightful look at the core fundamentals
Abbvie Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.83 and a Current Ratio set at 0.94.
Earnings per share (EPS) analysis for Abbvie Inc [ABBV] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABBV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Abbvie Inc go to 6.09%.
Abbvie Inc [ABBV]: Institutional Ownership
The top three institutional holders of ABBV stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ABBV stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ABBV stock with ownership which is approximately 5.8386%.
